News

Avernus to become exclusive supplier of SYNDROS® following approval by the Gulf Central Committee for Drug Registration

Medra Brasil to become exclusive supplier of Benuvia’s SYNDROS® (dronabinol) in Brazil following Anvisa approval

The Department of Veterans Affairs will conduct a proof-of-concept trial of Cannabis derivatives in Neuropathic Pain (CDNP) including Benuvia’s SYNDROS® (dronabinol) oral solution, CII

The US House of Representatives on Monday evening passed the Biosecure Act with broad bipartisan support…

Mr. Novak brings three decades of executive leadership experience in the pharmaceutical, biotech, and contract development and manufacturing organization (CDMO) industries

Benuvia Operations, LLC, a leader in the development of innovative pharmaceutical cannabinoid and psychedelic products, is excited to announce a strategic partnership with Bright Green Corporation